Organic growth and margin recovery continued, with gross margin up 430+ bps and Q4 EPS growth of 25% expected. Category softness led to revised guidance, but share gains and strong cash flow remain intact.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.